Raser Jeffrey 4
4 · Somaxon Pharmaceuticals, Inc. · Filed Jun 25, 2010
Insider Transaction Report
Form 4
Raser Jeffrey
Senior VP, Sales and Marketing
Transactions
- Sale
Common Stock
2010-06-24$4.67/sh−15,000$70,050→ 40,000 total
Footnotes (2)
- [F1]This sale was effected by the reporting person pursuant to a pre-planned selling program under Rule 10b5-1 adopted by the reporting person in 2009 that has been terminated.
- [F2]This sale was to have been made under Mr. Raser's pre-planned selling program on March 18, 2010, but the broker administering the program erroneously failed to effect the sale on such date. Mr. Raser was subject to a contractual restriction on selling shares that expired June 23, 2010. The broker effected this sale on June 24, 2010 and agreed to pay Mr. Raser an additional $2.6078 per share, making Mr. Raser's effective price per share $7.2778, which would have been Mr. Raser's sale price had this sale been effected on March 18, 2010.